Manufacturing news briefs — stories you might have missed

Memphasys claims defining milestone for Felix Reproductive technology company Memphasys has announced the successful data from a “pivotal clinical trial” for the Felix System, “confirming its best-in-class performance in sperm selection for Assisted Reproductive Technology (ART).” Conducted in partnership through Monash IVF, Memphasys said on Monday that the trial results show Felix as “non-inferior to…

Manufacturing news briefs – stories you might have missed

IDT Australia secures Sanofi contract Pharmaceutical development company IDT Australia has secured a follow on contract with pharma giant Sanofi Australia for preclinical formulation, development and manufacture of Sanofi’s messenger RNA (mRNA). The contract, worth up to $4 million, continues the company’s advancement of mRNA-based vaccine formulation, development and manufacture at IDT’s aseptic sterile injectables…

Applications open for NSW Plastics Research Program grants worth up to $500,000 each

The NSW Environment Protection Authority (EPA) has invited universities and government research institutions in the state to apply for a total of $1.25 million in grants available through the Plastics Research Program (PRP). Applications are open until September 5, and grants are valued at between $250,000 and $500,000 each.  According to the program’s description, funded…